Search Results - "Altomare, A."

Refine Results
  1. 1

    Perturbations of the AKT signaling pathway in human cancer by Altomare, Deborah A, Testa, Joseph R

    Published in Oncogene (14-11-2005)
    “…AKT/PKB (protein kinase B) kinases mediate signaling pathways downstream of activated tyrosine kinases and phosphatidylinositol 3-kinase. AKT kinases regulate…”
    Get full text
    Journal Article
  2. 2

    Homeostasis and the importance for a balance between AKT/mTOR activity and intracellular signaling by Altomare, D A, Khaled, A R

    Published in Current medicinal chemistry (01-08-2012)
    “…The AKT family of serine threonine kinases is of critical importance with regard to growth factor signaling, cell proliferation, survival and oncogenesis…”
    Get more information
    Journal Article
  3. 3

    PD-L1 blockade enhances anti-tumor efficacy of NK cells by Oyer, Jeremiah L., Gitto, Sarah B., Altomare, Deborah A., Copik, Alicja J.

    Published in Oncoimmunology (02-11-2018)
    “…Anti-PD-1/anti-PD-L1 therapies have shown success in cancer treatment but responses are limited to ~ 15% of patients with lymphocyte infiltrated, PD-L1…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Pharmacokinetic profile of bilberry anthocyanins in rats and the role of glucose transporters: LC–MS/MS and computational studies by Baron, G., Altomare, A., Regazzoni, L., Redaelli, V., Grandi, S., Riva, A., Morazzoni, P., Mazzolari, A., Carini, M., Vistoli, G., Aldini, G.

    “…•A LC-ESI–MS method for anthocyanins identification and quantitation in plasma was set-up and validated.•15 bilberry anthocyanins behave differently in term of…”
    Get full text
    Journal Article
  6. 6

    Development and validation of a LC–MS/MS assay for quantification of cisplatin in rat plasma and urine by Shaik, Abdul Naveed, Altomare, Deborah A., Lesko, Lawrence J., Trame, Mirjam N.

    “…•Cisplatin LC–MS/MS Method Validation using Agilent 6460 triple quad.•Derivatization of cisplatin with diethyldithiocarbamate for indirect estimation of…”
    Get full text
    Journal Article
  7. 7

    Augmented CPT1A Expression Is Associated with Proliferation and Colony Formation during Barrett’s Tumorigenesis by Bernard, Joshua N., Chinnaiyan, Vikram, Andl, Thomas, Le Bras, Gregoire F., Qureshi, M. Nasar, Altomare, Deborah A., Andl, Claudia D.

    “…Obesity is a known risk factor for the development of gastroesophageal reflux disease (GERD), Barrett’s Esophagus (BE) and the progression to esophageal…”
    Get full text
    Journal Article
  8. 8

    Cryopreserved PM21-Particle-Expanded Natural Killer Cells Maintain Cytotoxicity and Effector Functions In Vitro and In Vivo by Oyer, Jeremiah L, Croom-Perez, Tayler J, Dieffenthaller, Thomas A, Robles-Carillo, Liza D, Gitto, Sarah B, Altomare, Deborah A, Copik, Alicja J

    Published in Frontiers in immunology (07-04-2022)
    “…There is a great interest in developing natural killer (NK) cells as adoptive cancer immunotherapy. For off-the-shelf approaches and to conduct multicenter…”
    Get full text
    Journal Article
  9. 9

    Differential Expression of Polyamine Pathways in Human Pancreatic Tumor Progression and Effects of Polyamine Blockade on Tumor Microenvironment by Nakkina, Sai Preethi, Gitto, Sarah B, Pandey, Veethika, Parikh, Jignesh G, Geerts, Dirk, Maurer, Hans Carlo, Olive, Kenneth P, Phanstiel, 4th, Otto, Altomare, Deborah A

    Published in Cancers (20-12-2021)
    “…Pancreatic cancer is the fourth leading cause of cancer death. Existing therapies only moderately improve pancreatic ductal adenocarcinoma (PDAC) patient…”
    Get full text
    Journal Article
  10. 10

    RAD001 Inhibits Human Ovarian Cancer Cell Proliferation, Enhances Cisplatin-Induced Apoptosis, and Prolongs Survival in an Ovarian Cancer Model by Mabuchi, Seiji, Altomare, Deborah A, Cheung, Mitchell, Zhang, Lili, Poulikakos, Poulikos I, Hensley, Harvey H, Schilder, Russell J, Ozols, Robert F, Testa, Joseph R

    Published in Clinical cancer research (15-07-2007)
    “…Purpose: mTOR (mammalian target of rapamycin) plays a central role in regulating cell growth and cell cycle progression and is regarded as a promising…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14

    Reactive Carbonyl Species and Protein Adducts: Identification Strategies, Biological Mechanisms and Molecular Approaches for Their Detoxification by Aldini, Giancarlo, Altomare, Alessandra A

    Published in Antioxidants (28-04-2021)
    “…The Special issue is composed of 13 contributions: 9 research papers and 4 reviews [...]…”
    Get full text
    Journal Article
  15. 15

    FAS-Associated Factor 1 (FAF1): Diverse functions and implications for oncogenesis by Menges, Craig W., Altomare, Deborah A., Testa, Joseph R.

    Published in Cell cycle (Georgetown, Tex.) (15-08-2009)
    “…FAS-associated factor 1, FAF1, is an evolutionarily conserved protein that has several protein interaction domains.  Although FAF1 was initially identified as…”
    Get full text
    Journal Article
  16. 16

    PM21-particle stimulation augmented with cytokines enhances NK cell expansion and confers memory-like characteristics with enhanced survival by Oyer, Jeremiah L, Croom-Perez, Tayler J, Hasan, Md Faqrul, Rivera-Huertas, Javier A, Gitto, Sarah B, Mucha, Joanna M, Zhu, Xiang, Altomare, Deborah A, Igarashi, Robert Y, Copik, Alicja J

    Published in Frontiers in immunology (22-04-2024)
    “…NK cell therapeutics have gained significant attention as a potential cancer treatment. Towards therapeutic use, NK cells need to be activated and expanded to…”
    Get full text
    Journal Article
  17. 17

    Human serum albumin cysteinylation is increased in end stage renal disease patients and reduced by hemodialysis: mass spectrometry studies by Regazzoni, L, Del Vecchio, L, Altomare, A, Yeum, K-J, Cusi, D, Locatelli, F, Carini, M, Aldini, G

    Published in Free radical research (01-03-2013)
    “…The aim of the present work was to monitor the covalent modifications of human serum albumin (HSA) in end stage renal diseases (ESRD) non-diabetic patients,…”
    Get more information
    Journal Article
  18. 18

    Losses of both products of the Cdkn2a/Arf locus contribute to asbestos-induced mesothelioma development and cooperate to accelerate tumorigenesis by Altomare, Deborah A, Menges, Craig W, Xu, Jinfei, Pei, Jianming, Zhang, Lili, Tadevosyan, Ara, Neumann-Domer, Erin, Liu, Zemin, Carbone, Michele, Chudoba, Ilse, Klein-Szanto, Andres J, Testa, Joseph R

    Published in PloS one (19-04-2011)
    “…The CDKN2A/ARF locus encompasses overlapping tumor suppressor genes p16(INK4A) and p14(ARF), which are frequently co-deleted in human malignant mesothelioma…”
    Get full text
    Journal Article
  19. 19

    Phase II Study of Erlotinib in Patients With Malignant Pleural Mesothelioma: A Southwest Oncology Group Study by GARLAND, Linda L, RANKIN, Cathryn, GANDARA, David R, RIVKIN, Saul E, SCOTT, Katherine M, NAGLE, Raymond B, KLEIN-SZANTO, Andres J. P, TESTA, Joseph R, ALTOMARE, Deborah A, BORDEN, Ernest C

    Published in Journal of clinical oncology (10-06-2007)
    “…Malignant pleural mesothelioma (MPM) expresses high levels of epidermal growth factor receptor (EGFR), and preclinical studies have identified antitumor…”
    Get full text
    Journal Article
  20. 20

    Ag2WO4 as a multifunctional material: Fundamentals and progress of an extraordinarily versatile semiconductor by Gouveia, A.F., Roca, R.A., Macedo, N.G., Cavalcante, L.S., Longo, E., San-Miguel, M.A., Altomare, A., da Silva, G.S., Andrés, J.

    “…Silver tungstate (Ag2WO4) based materials are intensively studied because of their unique chemical and physical properties. Ag2WO4 polymorphs present discrete…”
    Get full text
    Journal Article